![Erin Lavelle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Ms. Erin M.
Lavelle is an Independent Director at Jade Biosciences, Inc. and an Independent Director at Avalyn Pharma, Inc. She is on the Board of Directors at Jade Biosciences, Inc., Jade Biosciences, Inc. (United States) and Avalyn Pharma, Inc. Ms. Lavelle was previously employed as an Executive VP, Chief Operating & Financial Officer by Eliem Therapeutics, Inc., an Independent Director by Neoleukin Therapeutics, Inc., a Chief Operating Officer by Lundbeck Seattle BioPharmaceuticals, Inc., and a General Manager by Amgen, Inc. She also served on the board at Vitaeris, Inc. She received her undergraduate degree from Yale University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AVALYN PHARMA INC -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JADE BIOSCIENCES, INC. | Director/Miembro de la Junta | 28/04/2025 |
| AVALYN PHARMA INC. | Director/Miembro de la Junta | 01/07/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| CLIMB BIO, INC. | Director Financiero/CFO | 10/03/2023 |
| ALDER BIOPHARMACEUTICALS, INC. | Director de Operaciones | 01/02/2020 |
| AMGEN INC. | Corporate Officer/Principal | 01/03/2018 |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Director/Miembro de la Junta | - |
| NEUROGENE INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
